Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by HighteawithIntrepidon Sep 09, 2017 4:38pm
166 Views
Post# 26675990

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:News

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:NewsThis is a copy of the first press release:
SRAM, a leading investment group in healthcare in China, will provide $23 million in 2017, $13 millionupfront and $10 million expected in H2 2017, to secure an initial 17% ownership of Prometic ChinaCo, with a right to increase it up to 25% with a further $10 millioninvestment related to milestones expected.

so the first question is when did we get the 13 million Q2 or Q3 and if we got the 10 million by the time we signed the deal on August release why didn't they say that?
If it was 13 million on closing the first press release is misleading as it should have said on closing of the deal.
 I am having issues accessing the slide presentation etc. and the Q2 financials has the deal closing in H2 which contradicts the above release so can agree we got the 13 million by August but I can't see the 10 million in black and white print so if you're able 
to copy and paste the 10 million info please do then I am okay with another months wiggle room in the cash burn. 
If you have copied the information into a traceable file I would appreciate viewing it. In my opinion PLI should have stated we got 13 million on yyyy mm dd and the 10 million on yyyy mm dd. HT



Bullboard Posts